Bausch Health Companies Inc. revenue by segment BHC

Annual Quarterly

Bausch Health Companies Inc. splits its revenue into 8 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $10.2 billion, 99% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	11,113	10,266	9,625	8,757	8,124	8,434	8,027	8,601	8,380	8,724	9,674
Product	11,005 +11.0% share 99.0%	10,156 +6.7% share 98.9%	9,518 +9.9% share 98.9%	8,663 +8.0% share 98.9%	8,025 -3.6% share 98.8%	8,328 +5.1% share 98.7%	7,924 -6.7% share 98.7%	8,489 +2.6% share 98.7%	8,271 -3.8% share 98.7%	8,595 share 98.5%	—
Pharmaceutical Products	—	—	—	2,251 +7.7% share 25.7%	2,090 +1.2% share 25.7%	2,066 +308.3% share 24.5%	506 -18.8% share 6.3%	623 share 7.2%	—	956 share 11.0%	—
Brandedand Other Generic Products	—	—	—	588 +11.6% share 6.7%	527 -27.1% share 6.5%	723 +184.6% share 8.6%	254 -2.3% share 3.2%	260 -66.8% share 3.0%	784 -4.3% share 9.4%	819 share 9.4%	—
Device Products	—	—	—	347 +15.7% share 4.0%	300 -2.6% share 3.7%	308 -76.5% share 3.7%	1,313 -13.8% share 16.4%	1,524 +1.3% share 17.7%	1,505 +5.9% share 18.0%	1,421 share 16.3%	—
Overthe Counter Products	—	—	—	179 share 2.0%	—	136 -89.6% share 1.6%	1,311 -0.8% share 16.3%	1,322 -6.4% share 15.4%	1,412 -7.7% share 16.8%	1,529 share 17.5%	—
Product And Service Other	108 -4.4% share 1.0%	110 +2.8% share 1.1%	107 +13.8% share 1.1%	94 -5.1% share 1.1%	99 -6.6% share 1.2%	106 +2.9% share 1.3%	103 -8.0% share 1.3%	112 +2.8% share 1.3%	109 -15.5% share 1.3%	129 share 1.5%	—
Price Appreciation Credit	46 share 0.4%	18 +0.0% share 0.2%	18 +63.6% share 0.2%	11 +10.0% share 0.1%	10 -41.2% share 0.1%	17 +13.3% share 0.2%	15 +36.4% share 0.2%	11 -64.5% share 0.1%	31 share 0.4%	—	—
Other Revenues	—	—	—	-1 -101.9% share -0.0%	52 +550.0% share 0.6%	8 -74.2% share 0.1%	31 -36.7% share 0.4%	49 -31.0% share 0.6%	71 +1.4% share 0.8%	70 share 0.8%	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: BHC (NYSE)
Fiscal year ends: December 31
Incorporated in: NJ
Headquarters: Quebec, Quebec, Canada
SEC filer status: Large accelerated filer
SEC CIK: 885590
Former names: Valeant Pharmaceuticals International, Inc. (until Jul 3, 2018); BIOVAIL Corp (until Sep 27, 2010); BIOVAIL CORP INTERNATIONAL (until Apr 7, 2010); BIOVAIL CORPORATION INTERNATIONAL (until Jan 5, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.